Figure 2From: The role of the maximum involvement of biopsy core in predicting outcome for patients treated with dose-escalated radiation therapy for prostate cancerKaplan-Meier estimates of (a) freedom from biochemical failure, (b) freedom from metastasis, (c) cause-specific survival, and (d) overall survival as a function of maximum involvement of biopsy core (MIBC). Cut-point of 60% generated from receiver operating characteristic curve analysis.Back to article page